Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Moca score sits at the center of this dementia and brain health question.
The Montreal Cognitive Assessment, or MoCA, uses a scoring system where different point ranges indicate distinct levels of cognitive function. A score of 26 or higher suggests normal cognition, while scores between 18 and 25 typically point to mild cognitive impairment (MCI). Scores of 10 to 17 indicate moderate cognitive decline, and anything below 10 reflects severe cognitive impairment. However, these numbers alone don’t tell the whole story—a single MoCA score is best understood as a snapshot of cognitive function at one point in time, not a definitive diagnosis of dementia or any permanent condition.
If your father scores 21 on a MoCA screening, for example, that result suggests mild cognitive impairment, but it doesn’t automatically mean Alzheimer’s disease or another dementia. It means further evaluation and ongoing monitoring are warranted. Understanding what a MoCA score actually means requires looking beyond the number itself to consider the person’s educational background, overall health, and how their cognitive function changes over weeks and months. The MoCA was specifically designed as a screening tool to identify people who need additional evaluation, not as a final diagnosis. This distinction matters enormously in clinical practice and for families navigating cognitive health concerns.
Table of Contents
- What Do Different MoCA Score Ranges Tell You About Cognitive Status?
- How Average Scores Differ Across Healthy Adults, MCI, and Dementia Populations
- Education Level and Why Raw Scores Need Interpretation, Not Just Comparison
- Why MoCA Serves as a Starting Point, Not a Final Diagnosis
- Tracking Decline Over Time Often Matters More Than a Single Score
- Population-Specific Norms and Why Global Standards Don’t Apply Everywhere
- The Future of Cognitive Assessment Beyond MoCA
- Conclusion
What Do Different MoCA Score Ranges Tell You About Cognitive Status?
The MoCA scoring system divides cognition into four main categories, each with distinct clinical implications. Scores between 26 and 30 points represent normal cognitive function and typically correspond to the performance of healthy adults with no cognitive concerns. If someone scores 28 on the MoCA, their performance falls well within the range that suggests their memory, attention, language, and thinking skills are working as expected for their age. Scores between 18 and 25 identify mild cognitive impairment. The average person with MCI scores around 22 points, clustering in the middle of this range. This is genuinely different from normal aging but doesn’t necessarily progress to dementia.
Someone with MCI might forget where they parked at the grocery store more often than they used to, or struggle to find a word in conversation, but these changes are noticeable enough that family members or friends comment on them. A person scoring 23 on the MoCA would fit this profile—cognitive changes present, but independence in daily life often remains intact. Moderate cognitive impairment, falling between 10 and 17 points on the MoCA, suggests more significant decline. People in this range often need reminders for appointments, may have trouble managing finances, or struggle to follow complex instructions. Scores below 10 reflect severe cognitive impairment, where day-to-day functioning becomes substantially compromised and caregiving needs increase dramatically. The difference between a score of 15 and a score of 8 represents not just a smaller number, but typically a much larger gap in independence and functioning.
How Average Scores Differ Across Healthy Adults, MCI, and Dementia Populations
research comparing large groups of people shows clear patterns in average MoCA scores across different cognitive statuses. Healthy adults without cognitive impairment score an average of 27.4 points, representing the upper end of normal function. People diagnosed with mild cognitive impairment average 22.1 points. Those with mild Alzheimer’s disease average 16 points, with individual scores typically ranging between 11 and 21. Additional research confirms Alzheimer’s disease scores around 16.2 on average, indicating substantial but not yet severe cognitive decline.
These averages are clinically useful because they establish baselines for what different groups typically score, but they come with an important limitation: individual variation is substantial. Not everyone with MCI scores 22, and not everyone with mild Alzheimer’s scores 16. Two people with identical Alzheimer’s diagnoses might score 13 and 19 on the MoCA, reflecting differences in which cognitive abilities are most affected. The MMSE screening test, for comparison, often produces different scores than the MoCA for the same person because it emphasizes different cognitive domains. This is why a single MoCA result must always be interpreted alongside clinical judgment, not as a standalone verdict.
Education Level and Why Raw Scores Need Interpretation, Not Just Comparison
The Montreal Cognitive Assessment is sensitive to education level in ways that require trained clinicians to interpret scores correctly. A raw score of 24 points means something quite different for someone with a university degree than for someone with a sixth-grade education. Neuroscience and cognitive testing research has established that people with higher educational attainment tend to have cognitive reserve—a built-in advantage in how well they perform on standardized tests, even when underlying cognitive function is equivalent. In practice, this means the MoCA includes education adjustments.
If someone with 12 years of education scores 24, that represents a different level of cognitive impairment than a score of 24 for someone with 16 years of education. A clinical psychologist or neurologist administering the MoCA will apply these adjustments when interpreting results, potentially adding a point to the raw score for people with fewer than 12 years of formal education. Without this adjustment, people with less educational background might be incorrectly flagged as having cognitive impairment when their actual cognitive status is normal. This becomes particularly critical in communities where average education levels vary significantly, or when evaluating adults who completed their schooling in countries with different educational systems.
Why MoCA Serves as a Starting Point, Not a Final Diagnosis
The MoCA was designed explicitly as a screening and monitoring tool—it identifies who needs further evaluation, not who has dementia. This distinction often gets blurred in clinical practice and in conversations between patients and doctors. A positive MoCA screening, meaning a score below 26, is a signal to pursue additional testing with specialists like neuropsychologists or neurologists, but it is not, by itself, a diagnosis of any condition. Misunderstanding this has real consequences for patients and families.
Someone might receive a MoCA score of 20, learn that this falls in the MCI range, and assume they have dementia or will inevitably develop it—when in reality, MCI is a transitional state that some people stay in for years, others improve from with proper intervention, and others do progress to dementia. The MoCA’s strength lies in its efficiency and objectivity; it can be given in a doctor’s office in 10 minutes and costs nothing. Its limitation is that cognitive assessment requires the full picture: detailed history from family members, evaluation of activities of daily living, imaging studies in some cases, and sometimes formal neuropsychological testing. The MoCA is the first piece of that puzzle, not the puzzle itself.
Tracking Decline Over Time Often Matters More Than a Single Score
One of the most important but frequently overlooked insights about MoCA scores is that the rate of change is often more meaningful clinically than the absolute number. A person who scores 26 on their baseline MoCA and then scores 24 six months later shows a decline of 2 points. A person who scores 22 on baseline and stays at 22 after six months is stable. These trajectories predict very different outcomes and should prompt very different responses from their healthcare team.
Longitudinal tracking—measuring cognition repeatedly over time—is why family members’ observations carry so much weight in dementia evaluation. A spouse who says “He’s been getting worse the last two years” is providing longitudinal data that a single MoCA score cannot capture. Conversely, someone whose scores remain stable across multiple administrations over a year probably doesn’t need immediate escalation to specialty care, even if that score sits in the MCI range. This is why clinicians typically recommend follow-up MoCA screening at six- to twelve-month intervals for people with concerns about cognitive decline. The pattern of scores—staying stable, declining slowly, or declining rapidly—tells a far more complete story than any single test result.
Population-Specific Norms and Why Global Standards Don’t Apply Everywhere
Recent research from 2025 published in peer-reviewed journals demonstrates that cognitive assessment norms vary meaningfully across different populations and countries. A study examining MoCA performance in Arab populations found that country-specific and population-adjusted norms produced more accurate interpretations than applying universal cutoff scores. This reflects broader findings in neuroscience: cognitive aging, education systems, literacy rates, cultural factors influencing test performance, and healthcare access all influence how people score on standardized assessments.
For practitioners and families, this means that interpreting a MoCA score requires knowing something about the norms relevant to the person being tested. A score of 24 might be normal for someone in one country or cultural context and concerning in another, not because of actual cognitive differences but because of how education, language, and cultural factors influence test performance. Organizations administering the MoCA in diverse communities increasingly recognize this and seek locally developed norms rather than relying on scores developed primarily in North American populations. This evolving understanding helps prevent both over-diagnosis in some groups and missed diagnosis in others.
The Future of Cognitive Assessment Beyond MoCA
While the Montreal Cognitive Assessment remains the gold standard screening tool in most clinical settings, the field of cognitive assessment is evolving. Digital cognitive testing platforms, biomarker testing (like blood tests for Alzheimer’s proteins), and neuroimaging advances are beginning to supplement or potentially replace some traditional screening tools.
However, MoCA’s simplicity, cost-effectiveness, and decades of validation research mean it will likely remain central to dementia screening for the foreseeable future. The broader trend in cognitive health is moving toward earlier detection and prevention-focused approaches rather than waiting for cognitive impairment to reach moderate or severe levels before intervening. This shift emphasizes the importance of understanding what different MoCA scores mean not as fixed judgments about a person’s future, but as information that informs ongoing monitoring and proactive care decisions.
Conclusion
Understanding a MoCA score requires moving beyond the number itself to grasp what the score actually represents: a snapshot of cognitive function at one moment, a screening indicator that may warrant further evaluation, and a baseline for measuring change over time. A score of 26 or higher indicates normal cognition; 18 to 25 suggests mild cognitive impairment; 10 to 17 indicates moderate decline; and below 10 reflects severe impairment.
However, education level, population-specific norms, and individual variation all influence how to interpret these ranges correctly. If you or a family member receives a MoCA score, use it as a starting point for conversation with your healthcare provider about what additional evaluation might be needed, what symptoms to monitor, and how frequently to retest. Cognitive health is rarely static, and MoCA’s greatest clinical value lies not in any single score but in tracking how cognition changes over weeks and months—helping you and your doctor identify what’s happening early enough to pursue interventions that can help.
You Might Also Like
- Why Dementia Diet Research Often Looks Different for Women
- Why Women’s Nutrition Matters in Dementia Research
- Why HRT Research Is Complicated for Dementia Prevention
For more, see NIH MedlinePlus — dementia.
